Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.

Lopez del Amo JM, Fink U, Dasari M, Grelle G, Wanker EE, Bieschke J, Reif B.

J Mol Biol. 2012 Aug 24;421(4-5):517-24. doi: 10.1016/j.jmb.2012.01.013. Epub 2012 Jan 28.

PMID:
22300765
2.

Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β species.

Hyung SJ, DeToma AS, Brender JR, Lee S, Vivekanandan S, Kochi A, Choi JS, Ramamoorthy A, Ruotolo BT, Lim MH.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3743-8. doi: 10.1073/pnas.1220326110. Epub 2013 Feb 20.

3.

A cellular lipidomic study on the Aβ-induced neurotoxicity and neuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profiling and multivariate analysis.

Zhang H, Wang JR, Yau LF, Ho HM, Chan CL, Hu P, Liu L, Jiang ZH.

Mol Biosyst. 2012 Oct 30;8(12):3208-15. doi: 10.1039/c2mb25126d.

PMID:
23032920
4.

The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization.

Tay WM, Huang D, Rosenberry TL, Paravastu AK.

J Mol Biol. 2013 Jul 24;425(14):2494-508. doi: 10.1016/j.jmb.2013.04.003. Epub 2013 Apr 11.

PMID:
23583777
5.

Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils.

Grelle G, Otto A, Lorenz M, Frank RF, Wanker EE, Bieschke J.

Biochemistry. 2011 Dec 13;50(49):10624-36. doi: 10.1021/bi2012383. Epub 2011 Nov 16.

PMID:
22054421
6.

Molecular mechanism of the inhibition of EGCG on the Alzheimer Aβ(1-42) dimer.

Zhang T, Zhang J, Derreumaux P, Mu Y.

J Phys Chem B. 2013 Apr 18;117(15):3993-4002. doi: 10.1021/jp312573y. Epub 2013 Apr 9.

PMID:
23537203
7.

Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.

Dasari M, Espargaro A, Sabate R, Lopez del Amo JM, Fink U, Grelle G, Bieschke J, Ventura S, Reif B.

Chembiochem. 2011 Feb 11;12(3):407-23. doi: 10.1002/cbic.201000602. Epub 2011 Jan 10.

PMID:
21290543
8.

Electroanalysis of the interaction between (-)-epigallocatechin-3-gallate (EGCG) and amyloid-β in the presence of copper.

Zhang B, Cheng XR, da Silva IS, Hung VW, Veloso AJ, Angnes L, Kerman K.

Metallomics. 2013 Mar;5(3):259-64. doi: 10.1039/c3mt20106f.

PMID:
23443273
9.

Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice.

Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT.

J Nutr. 2009 Oct;139(10):1987-93. doi: 10.3945/jn.109.109785. Epub 2009 Aug 5.

10.

Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease.

La Porte SL, Bollini SS, Lanz TA, Abdiche YN, Rusnak AS, Ho WH, Kobayashi D, Harrabi O, Pappas D, Mina EW, Milici AJ, Kawabe TT, Bales K, Lin JC, Pons J.

J Mol Biol. 2012 Aug 24;421(4-5):525-36. doi: 10.1016/j.jmb.2011.11.047. Epub 2011 Dec 13.

PMID:
22197375
11.

Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.

Kim CY, Lee C, Park GH, Jang JH.

Arch Pharm Res. 2009 Jun;32(6):869-81. doi: 10.1007/s12272-009-1609-z. Epub 2009 Jun 26.

PMID:
19557365
12.

Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.

Cheng XR, Hau BY, Veloso AJ, Martic S, Kraatz HB, Kerman K.

Anal Chem. 2013 Feb 19;85(4):2049-55. doi: 10.1021/ac303181q. Epub 2013 Jan 29.

PMID:
23276205
13.

Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease.

Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, Hoshi M, Nussinov R, Ishii Y.

Nat Struct Mol Biol. 2015 Jun;22(6):499-505. doi: 10.1038/nsmb.2991. Epub 2015 May 4.

14.

Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.

Smid SD, Maag JL, Musgrave IF.

Food Funct. 2012 Dec;3(12):1242-50. doi: 10.1039/c2fo30075c. Review.

PMID:
22929970
15.

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.

Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R.

Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16742-7. Epub 2002 Dec 12.

16.

Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers.

Fawver JN, Duong KT, Wise-Scira O, Petrofes Chapa R, Schall HE, Coskuner O, Zhu X, Colom LV, Murray IV.

J Alzheimers Dis. 2012;32(1):197-215.

PMID:
22785403
17.

Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.

Scherzer-Attali R, Farfara D, Cooper I, Levin A, Ben-Romano T, Trudler D, Vientrov M, Shaltiel-Karyo R, Shalev DE, Segev-Amzaleg N, Gazit E, Segal D, Frenkel D.

Neurobiol Dis. 2012 Jun;46(3):663-72. doi: 10.1016/j.nbd.2012.03.005. Epub 2012 Mar 19.

PMID:
22449754
18.

Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.

Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J.

Brain Res. 2008 Jun 12;1214:177-87. doi: 10.1016/j.brainres.2008.02.107. Epub 2008 Apr 7.

PMID:
18457818
19.

Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.

Han M, Liu Y, Tan Q, Zhang B, Wang W, Liu J, Zhang XJ, Wang YY, Zhang JM.

Eur J Pharmacol. 2011 Apr 25;657(1-3):104-10. doi: 10.1016/j.ejphar.2011.01.065. Epub 2011 Feb 17.

PMID:
21316359
20.

Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity.

Bastianetto S, Yao ZX, Papadopoulos V, Quirion R.

Eur J Neurosci. 2006 Jan;23(1):55-64.

PMID:
16420415

Supplemental Content

Support Center